Pfizer (PFE) Net Margin (QoQ) (2009 - 2026)
Powered by 
Analysis
Pfizer (PFE) Net Margin (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.43 Bn | 620.67 Bn | 17.26 Bn |
| 2 | AbbVie | 446.70 Bn | 440.13 Bn | 12.70 Bn |
| 3 | Merck | 358.22 Bn | 351.08 Bn | 12.21 Bn |
| 4 | Novartis Ag | 268.35 Bn | 260.66 Bn | 11.24 Bn |
| 5 | Pfizer | 156.81 Bn | 145.11 Bn | 10.94 Bn |
| 6 | Sanofi | 52.18 Bn | 44.80 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.02 Bn | 43.02 Bn | - |
| 8 | Incyte | 24.83 Bn | 20.29 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.38 Bn | 18.72 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.89 Bn | 15.50 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | -2,024.00 |
| Mar 29, 2026 | 2,800.00 |
| Dec 31, 2025 | -3,066.00 |
| Sep 28, 2025 | 133.00 |
| Jun 29, 2025 | -170.00 |
| Sep 29, 2024 | 1,628.00 |
| Jun 30, 2024 | -2,063.00 |
| Mar 31, 2024 | 11,883.00 |
| Jul 2, 2023 | -1,208.00 |
| Jul 3, 2022 | 506.00 |
| Oct 3, 2021 | 286.00 |
| Jul 4, 2021 | -407.00 |
| Sep 27, 2020 | -786.00 |
| Jun 28, 2020 | 209.00 |
| Mar 29, 2020 | 6,440.00 |
| Dec 31, 2019 | -9,164.00 |
| Sep 29, 2019 | 2,248.00 |
| Jun 30, 2019 | 846.00 |
| Mar 31, 2019 | 6,281.00 |
| Dec 31, 2018 | -6,416.00 |